Merit Medical Systems Inc (MMSI) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.

Total Cash From Operating Activities Chart for Merit Medical Systems Inc

Merit Medical Systems Inc (MMSI) operating cash flow for FY2025 was USD 297.4M, a 34.7% change from FY2024. Merit Medical Systems Inc's operating cash flow grew from USD 300.0K in 1991 to USD 297.4M in 2025 (99023.7% over 34 years). Operating cash flow compound annual growth rate: 5-year CAGR of 12.5%, 10-year CAGR of 15.7%, 20-year CAGR of 17.9%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$5.57B
Implied Share Price
$93.30
Enterprise Value
$5.58B
Revenue (TTM)
$1.58B
EBITDA
$338.94M
Profit Margin
9.22%
Trailing P/E
38.40
Forward P/E
18.94
Price/Book (MRQ)
3.10
Price/Sales (TTM)
3.53
EV/EBITDA
15.42
EV/Revenue
3.54
Dividend Yield
—
Book Value
$28.13
Free Cash Flow (FY2025)
$212.53M
Free Cash Flow Yield
3.82%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.